*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Jeffrey Valdez (valdez@cc.gatech.edu)
Jimeng Sun (jsun@cc.gatech.edu)
Summary Sentence: CHAI Seminar Series: Jon Duke, MD MS, Georgia Institute of Technology and GTRI
Full Summary: No summary paragraph submitted.
Dr. Jon Duke, MD MSSpeaker: Jon Duke, MD MS, Principal Research Scientist and Director of the Center for Health Analytics at the Georgia Tech Research Institute. Joint appointment at the College of Computing at Georgia Institute of Technology.
Date: Tuesday, February 6, 2018
Time: 03:00pm – 04:15pm
Location: Klaus Advanced Computing Building, Room 2443
Title: Precision Medicine at Georgia Tech: Introduction to the Health Data Analytics Platform
Abstract: Conducting health research is complex, from accessing health data to running analytics to building interoperable applications. The Georgia Tech Health Data Analytics Platform (HDAP) is designed to expedite the process of health research through 1) accessible datasets, 2) analytics tools, and 3) interoperable FHIR APIs and and a FHIR application deployment environment. In this presentation, we will discuss precision medicine research, the use of natural language processing, and the HDAP platform.
Bio: Dr. Jon Duke is Principal Research Scientist at the Georgia Tech Research Institute where he is Director of the Center for Health Analytics and Informatics and on faculty in the Georgia Tech College of Computing. He is former Director of Drug Safety Analytics and Advanced Text Mining at the Regenstrief Center for Biomedical Informatics in Indianapolis. He has led over $21 million in funded research for industry, government, and foundation partners. Dr. Duke’s research focuses on advancing techniques for identifying patients of interest from diverse data sources with applications spanning research, quality, and clinical domains. He led the Merck-Regenstrief Partnership in Healthcare Innovation and was a founding member of OHDSI, an open-source international health data analytics collaborative. In addition to numerous peer-reviewed publications, his work has been featured in the lay media including the New York Times, NPR, and MSNBC. Dr. Duke completed his medical degree at Harvard Medical School and a master's in human-computer interaction at Indiana University.
